AUTHORS
Holly Adams, BSc, Jessica Salmon, PhD2, Ian Parish, PhD3, Andrew Charles Perkins, MBBS, PhD4
AFFILIATIONS
1 Monash University, Melbourne, Victoria, Australia
2 Monash University, Melbourne, Victoria, Australia
3 Peter Maccallum Cancer Centre, Melbourne CBD, Victoria, Australia
4 Monash University, Melbourne, Victoria, Australia
ABSTRACT
The Kruppel-like factor (KLF) family of transcription factors work in feed forward and feedback loops to regulate many important processes in T cells including migration, effector functions and exhaustion. KLF3 is a transcriptional repressor. In the context of LCMV infection, CRISPR editing of Klf3 results in increased Teff numbers and reduced Texh cells [1]. In this work, we have examined T cell generation and function in Klf3-/- mice, which have chronic skin inflammation and increased sensitivity to LPS [2]. Single cell RNA-seq of Klf3-/- splenocytes revealed an aberrant transcriptome in both CD4 and CD8 T cells, with upregulation of a common set of genes, consistent with a transcriptional repression role for KLF3. Differentially expressed genes includes those involved in inflammation, migration and cell cycle control. There was marked upregulation of Klf8 and Klf12, two related members of the KLF family, suggesting cross regulation and possible redundancy between these family members. There was also marked upregulation of E2f2, a known direct target of KLF3 in erythroid cells [3]. Klf3-/- mice have less CD8+ and gd T cells in the spleen, but increased numbers in the LNs and tissues, consistent with a role for KLF3 in migration. There is increased CD44 expression in Klf3-/- T cells consistent with spontaneous activation. The thymus of Klf3-/- mice is abnormal with an expansion of DN2 cells and reduced numbers of DN3 cells, with reduced mature CD8+ single positive T cell numbers. This is accompanied by markedly increased incorporation of BrdU in the DN population, consistent with a suppressive role for KLF3 in E2f2 gene expression. This stage is normally characterised by a decrease in proliferation which allows time for b-TCR rearrangement to occur. We will present data that addresses the consequences of this aberrant cell cycle control with respect to positive and negative selection in the thymus. To address whether these phenotypes are cell autonomous of not, we generated a conditional allele of Klf3 in which mCherry is linked to the coding sequence via a cleavable 2A peptide, and the last exon is flanked by LoxP sites. In these mice mCherry serves as a marker of KLF3 expression; it is highest in CD8 T cells, and particularly high in DN2 thymocytes. We crossed these mice to an SCL-creTM driver strain to conditionally delete Klf3 in ~50% HSCs and their progeny. Conditional knockout cells have the same phenotype as full knockout cells in the thymus and periphery whereas mCherry+ (non-deleted) cells in the same mice have a normal phenotype. This internal control confirms a cell autonomous role for KLF3 in cell cycle control, migration, activation and exhaustion.
References:
Shen, J., et al., Kruppel-like factors 2 and 3 regulate T cell exhaustion by directing T cell residency and migration. Immunity, 2026.
Salmon J., R.C., Bender M., Mitchell H.L., Fox V., Magor G.W., Sweet M., Perkins A.C., KLF3 represses the inflammatory response in macrophages. Blood, 2020. 136: p. 36.
Ilsley, M.D., et al., Kruppel-like factors compete for promoters and enhancers to fine-tune transcription. Nucleic Acids Res, 2017. 45(11): p. 6572–6588.
DISCLOSURES
Andrew Charles Perkins, MBBS, PhD: Kartos Therapeutics - Honoraria; CTI - Honoraria; GSK - Honoraria; Silence Therapeutics - Honoraria; Novartis - Honoraria; Incyte - Honoraria; GSK - Consultancy (Includes expert testimony); Kartos Therapeutics - Consultancy (Includes expert testimony); Incyte - Consultancy (Includes expert testimony); Novartis - Consultancy (Includes expert testimony); CTI - Consultancy (Includes expert testimony); Silence Therapeutics - Consultancy (Includes expert testimony)